SBI Life Insurance Share Price Target at Rs 2,112: Geojit Reaffirms Bullish View
SBI Life Insurance Company, backed by a BUY recommendation from Geojit Investments, presents a compelling long-term growth narrative anchored in operational resilience, product diversification, and consistent value creation. The insurer has delivered robust premium growth, strengthened persistency ratios, and maintained a disciplined balance sheet. With a revised target price of Rs. 2,112 (implying ~16% upside from CMP Rs. 1,820), the outlook remains optimistic, supported by expanding embedded value, rising profitability, and strategic focus on protection-led growth. Despite near-term sectoral headwinds, SBI Life’s scalable distribution, digital execution, and strong capital adequacy position it as a structurally sound compounder in India’s evolving insurance landscape.
Geojit Reaffirms BUY Call with Upside Potential
Investment Thesis: Geojit Investments has reiterated its BUY stance on SBI Life Insurance, setting a target price of Rs. 2,112 based on 1.8x FY28E EVPS. At the current market price of Rs. 1,820, the stock offers a potential upside of approximately 16%, making it an attractive proposition for medium- to long-term investors.
Valuation Comfort: The stock trades at a P/EV of 2.2x for FY26, expected to moderate to 1.5x by FY28, indicating improving valuation comfort alongside earnings growth.
Premium Growth Momentum Remains Intact
Quarterly Strength: In Q4FY26, net premium income rose 16% YoY to Rs. 27,684 crore, driven by a sharp 37.4% growth in single premium and a steady 13.9% increase in renewal premiums.
Annual Expansion: For FY26, gross written premium surged 19% YoY to Rs. 1,01,290 crore, underpinned by robust new business growth of 20% and renewal premium growth of 19%.
Future Trajectory: Net premium is projected to grow at a CAGR of ~13–14% through FY28, reaching Rs. 1,28,619 crore, highlighting sustained demand visibility.
Profitability and Value Creation Strengthen
Stable Earnings Base: Reported PAT for FY26 stood at Rs. 2,470 crore, marking a modest 2.4% YoY increase, while future estimates indicate a sharp 28.6% growth in FY27.
Embedded Value Expansion: Embedded value (EV) grew 15% YoY to Rs. 80,790 crore, reflecting strong long-term profitability and efficient capital deployment.
Margins Holding Firm: Value of New Business (VoNB) rose 12% YoY to Rs. 6,670 crore, with margins remaining stable at 27.5%, supported by favorable product mix and operational efficiency.
Operational Efficiency and Persistency Trends Improve
Persistency Gains: The 13th-month persistency ratio improved to 87.9% from 87.4%, indicating better customer retention and improved policyholder engagement.
Cost Discipline: Expense ratios remain under control, with total expenses at ~11.1% of premium in FY26, expected to decline further as scale benefits kick in.
Digital Push: Enhanced automation and digital integration are expected to streamline processes, improving both customer experience and cost efficiency.
Balanced Product Mix and Distribution Strength
Diversified Offerings: SBI Life continues to benefit from a balanced mix across ULIPs, protection, annuity, and non-linked products, reducing dependency on market-linked volatility.
Distribution Expansion: The company is aggressively expanding its agency channel through new branch openings while scaling direct and online channels.
Protection Focus: A strategic shift toward protection and non-ULIP products is expected to enhance margins and earnings quality.
Assets Under Management and Portfolio Quality
AUM Growth: Assets under management increased 9% YoY to Rs. 4,87,160 crore, reflecting steady inflows and market stability.
High-Quality Portfolio: The investment portfolio maintains a prudent debt-equity mix of 62:38, with 94% of debt investments rated AAA or sovereign, ensuring low credit risk.
Financial Snapshot and Key Metrics
| Metric | FY26 | FY27E | FY28E |
|---|---|---|---|
| Net Premium (Rs. Cr) | 99,956 | 113,076 | 128,619 |
| Net Profit (Rs. Cr) | 2,470 | 3,178 | 3,509 |
| EPS (Rs.) | 24.6 | 31.7 | 35.0 |
| EVPS (Rs.) | 805.4 | 974.3 | 1,179.1 |
| RoE (%) | 12.9 | 16.3 | 17.7 |
Management Outlook and Strategic Direction
Growth Visibility: Management remains confident of sustaining APE growth of ~14%, aligned with historical trends and supported by distribution expansion.
Margin Guidance: VoNB margins are expected to remain in the 26–28% range, with a target of sustaining above 27%.
Product Innovation: Upcoming launches in retirement and annuity segments are likely to unlock new revenue streams.
Sector Challenges and External Risks
Near-Term Headwinds: The insurance sector witnessed sluggish growth in the recent quarter due to geopolitical uncertainties impacting investor sentiment.
Market Sensitivity: Being partially linked to financial markets, ULIP-heavy segments remain exposed to volatility in equity markets.
Execution Risk: Sustaining growth in protection products and maintaining persistency ratios will be critical.
Investment Verdict: Structural Compounder with Clear Upside
Why Investors Should Consider: SBI Life stands out as a structurally strong life insurer with consistent premium growth, expanding embedded value, and disciplined execution.
Target and Levels:
CMP: Rs. 1,820
Target Price: Rs. 2,112
Upside Potential: ~16%
Final Take: Despite short-term sectoral volatility, SBI Life’s robust fundamentals, strong capital position, and clear growth roadmap make it a compelling BUY for investors seeking exposure to India’s underpenetrated insurance sector with long-term compounding potential.
